Literature DB >> 19169174

The prevalence of overweight and obesity in veterans with multiple sclerosis.

Seema R Khurana1, Alyssa M Bamer, Aaron P Turner, Rohini V Wadhwani, James D Bowen, Steve L Leipertz, Jodie K Haselkorn.   

Abstract

OBJECTIVES: To estimate the prevalence and factors associated with overweight and obesity in veterans with multiple sclerosis (MS) enrolled in the Veterans Health Administration (VA) and to compare the prevalence in this group with gender-specific published rates for the general population of veterans receiving outpatient care at VA medical facilities.
DESIGN: Cross-sectional cohort study linking electronic medical record information to mailed survey from 1999 to 2004. A total of 4703 veterans with MS enrolled in VA who returned questionnaires as part of two cross-sectional studies. Main outcome measures included body mass index, demographic information, Veteran RAND 36-item Health Survey, frequency of physical exercise, and other health conditions.
RESULTS: Overall, 28% of female and 42.8% of male veterans with MS were overweight. Another 25% of women and 21.2% of male veterans met the criteria for obesity. Compared with a historical cohort of veterans enrolled in the VA, veterans with MS had a slightly higher adjusted prevalence of overweight than did veterans in general (42.3% vs. 39.6%, respectively) but a lower adjusted prevalence of obesity (20.1% vs. 33.1%). In adjusted logistic regression, age, smoking, and lower levels of pain were associated with a lower likelihood of overweight or obesity. Being male, married, employed and having arthritis and diabetes were associated with a greater likelihood of overweight or obesity.
CONCLUSIONS: Overweight and obesity are a problem for more than 60% of veterans with MS in the VA. Screening for overweight and obesity should be done routinely. Interventions to prevent and manage excessive weight in individuals with MS should be developed and evaluated.

Entities:  

Mesh:

Year:  2009        PMID: 19169174     DOI: 10.1097/PHM.0b013e318194f8b5

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  24 in total

1.  Depressive Symptoms in Bariatric Surgery Patients with Multiple Sclerosis.

Authors:  Carolyn J Fisher; Leslie J Heinberg; Brittany Lapin; Ali Aminian; Amy B Sullivan
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

Review 2.  Dietary Interventions and Multiple Sclerosis.

Authors:  Ghadah Altowaijri; Allison Fryman; Vijayshree Yadav
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

Review 3.  Wellness and the Role of Comorbidities in Multiple Sclerosis.

Authors:  Brandon P Moss; Mary R Rensel; Carrie M Hersh
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

4.  The Multiple Sclerosis Centers of Excellence: A Model of Excellence in the VA.

Authors:  Michelle H Cameron; Jodie K Haselkorn; Mitchell T Wallin
Journal:  Fed Pract       Date:  2020-04

5.  Vascular function and multiple sclerosis.

Authors:  Anette S Fjeldstad; John McDaniel; Melissa A H Witman; Steve J Ives; Jia Zhao; John W Rose; James Hannon; D Walter Wray; Russell S Richardson
Journal:  J Neurol       Date:  2011-05-05       Impact factor: 4.849

Review 6.  Comorbidity in multiple sclerosis: implications for patient care.

Authors:  Ruth Ann Marrie
Journal:  Nat Rev Neurol       Date:  2017-03-17       Impact factor: 42.937

7.  Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Authors:  Anja Thormann; Melinda Magyari; Nils Koch-Henriksen; Bjarne Laursen; Per Soelberg Sørensen
Journal:  J Neurol       Date:  2016-10-03       Impact factor: 4.849

Review 8.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

Review 9.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

Review 10.  Modifiable comorbidities and disability in multiple sclerosis.

Authors:  Shannon Overs; Christina M Hughes; Jodie K Haselkorn; Aaron P Turner
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.